Formulary Watch |

Nasal spray offers promise for treatment-resistant depression, but proceed with caution. 

How FDA Chief Gottlieb’s resignation could impact the pharma industry.

The recalls of a widely used hypertension blood drug due to carcinogenic impurities are expanding.

FDA is warning about an increased risk of death and blood clots in the lungs in patients with rheumatoid arthritis taking a specific dosage of this drug.

Many patients who were prescribed fentanyl should not have received the drug, a new study said.

FDA is requiring the addition of a Black Box Warning to a gout drug that has an increased risk of death.

FDA approved first interoperable insulin pump, as well as the only FDA-approved drug for patients with a neglected tropical disease.

In his recent State of the Union address, President Trump promised to continue lowering drug prices and fund research for HIV/AIDS and childhood cancer. Here are the ways experts say he will implement those pledges.

FDA warns companies illegally selling drugs and dietary supplements claiming to cure Alzheimer’s and other conditions.

FDA approved the first generic of a popular inhaler to treat asthma and chronic obstructive pulmonary disease

CVS Health adds new migraine drugs to its list of covered drugs, but excludes one rival treatment.

FDA approves cabozantinib to treat patients with hepatocellular carcinoma, a community in need of new therapeutic options.

A new report details the financial strain rising drug prices are having on patients and hospitals alike.

FDA cleared the first generic tablet version of a top-selling epilepsy drug.

New legislation designed to curb drug costs comes on the heels of many pharma makers raising prices this year as well as payers saying they expect higher drug acquisition costs.

FDA approved a record number of novel treatments in 2018.

Soon after FDA warned the manufacturer involved in a massive nationwide recall of valsartan- and losartan-containing drugs, the recall is expanding. Find out why.

Two new therapies approved by FDA signal significant advancement in treating rare blood diseases.

Fluoroquinolone antibiotics can increase the occurrence of rare but serious events of ruptures or tears in the aorta, FDA said in a new warning.

 A new non-small cell lung cancer (NSCLC) treatment is available to healthcare providers immediately.  

After an expanded recall of the blood pressure medication valsartan, FDA is warning the manufacturer of the carcinogenic ingredient involved.

Two major drug recalls in the last week include an expanded recall of a widely used blood pressure medication as well as over-the-counter infant ibuprofen.

Find out how healthcare organizations and analysts feel about new Medicare Part D proposals and drug pricing.

Here are the top 2 novel cancer drugs cleared by the agency.

FDA approved the first biosimilar to rituximab (Rituxan, Genentech) to treat non-Hodgkin lymphoma.

FDA approved an autoinjector to treat rheumatoid arthritis and other diseases.